Moderator: Noopur Raje, MD (Massachusetts General Hospital)
Panelists:
Reena Jayani-Kosarzycki, MD (Vanderbilt University Medical Center)
Andrew Kuykendall, MD (Moffitt Cancer Center)
Sponsored by Pfizer
8:50 AM
Evolving Diagnostics in Iron Deficiency Anemia
Angela Weyand, MD (University of Michigan)
8:58 AM
The Bleeding Patient Consult
Michelle Chi, MD (Vanderbilt Health)
9:06 AM
New Developments in Sickle Cell Disease
Scott Peslak, MD, PhD (University of Pennsylvania)
9:14 AM
TTP/HUS
Spero Cataland, MD (The Ohio State University Comprehensive Cancer Center)
9:22 AM
Managing Thrombosis
Adam Cuker, MD, MS (University of Pennsylvania)
9:30 AM
Panel Discussion + Q&A
9:48 AM
MGUS/ SMM
Suzanne Lentzsch, MD, PhD (Columbia University Medical Center)
9:56 AM
CHIP/CCUS
Zhuoer Xie, MD, MS (Moffitt Cancer Center)
10:04 AM
MBL: Implications on Infectious Risk
Sameer Parikh, MBBS (Mayo Clinic)
10:12 AM
Panel Discussion + Q&A
11:00 AM
1L CLL Debate: Single Agent Monotherapy Vs Fixed Duration Combos
Adam Kittai, MD (Mount Sinai Health System)
Callie Coombs, MD (University of California Irvine) n
11:20 AM
MM
Amrita Krishnan, MD, FACP (City of Hope)
11:28 AM
DLBCL
Ryan Lynch, MD (Fred Hutch Cancer Center)
11:36 AM
Hodgkin’s
Boyu Hu, MD (Huntsman Cancer Institute)
11:44 AM
Indolent Lymphomas
Liz Brém, MD (Univeristy of California-Irvine)
11:52 AM
Panel Discussion + Q&A
1:40 PM
MF
John Mascarenhas, MD (Mount Sinai Health System)
1:48 PM
CML
Elias Jabbour
1:56 PM
MDS
Anthony Hunter, MD (Emory Winship Cancer Institute)
2:04 PM
MPNs
Gabriela Hobbs, MD (Massachusetts General Hospital)
2:12 PM
Panel Discussion + Q&A
2:32 PM
Defining High Risk Disease in Lymphoid Malignancies
Jeremy Abramson, MD (Harvard Medical School)
2:40 PM
HR MM: Time For A Paradigm Change?
Natalie Callander, MD (University of Wisconsin)
2:48 PM
TP53m MDS and AML
David Sallman, MD (Moffitt Cancer Center)
2:56 PM
Panel Discussion + Q&A
3:45 PM
Renal Insufficiency in Multiple Myeloma
Rahul Banerjee, MD, FACP (Fred Hutch Cancer Center)
3:53 PM
How To Tackle Curative Intent in Lymphoma Patients With Cardiac Comorbidities
Sarah Rutherford, MD (Weill Cornell Medicine)
4:01 PM
MDS/MPN Overlap Syndromes
Eric Padron, MD (Moffitt Cancer Center)
4:09 PM
AML: First-line Approach To Older, Fit Patients With AML (Induction vs. HMA/Ven)
Dan Pollyea, MD, MS (University of Colorado School of Medicine)
Jeffrey Lancet, MD (Moffitt Cancer Center)
4:29 PM
Panel Discussion + Q&A
8:45 AM
MRD in AML: Who, What, When, and How?
Chris Hourigan
8:53 AM
Defining The Value of uMRD in CLL
Chaitra Ujjani, MD (Fred Hutch Cancer Center)
9:01 AM
MRD in MM: How, When and Why?
Noopur Raje, MD (Massachusetts General Hospital)
9:09 AM
ctDNA in Lymphoma
9:17 AM
Debate: Is Len Until Progression Still The Optimal Maintenance in The Quad Era?
Peter Voorhees, MD (Atrium Health Levine Cancer Institute)
Faith Davies, MD (NYU Langone Health)
9:37 AM
Panel Discussion + Q&A
9:55 AM
Multiple Myeloma
Caitlin Costello, MD (University of California-San Diego)
10:03 AM
CLL
Jacqueline Barrientos, MD, MS (Mount Sinai Health System)
10:11 AM
iNHL
Krish Patel, MD (Sarah Cannon Research Institute)
10:19 AM
AML
Rami Komrokji, MD (Moffitt Cancer Center)
10:27 AM
Panel Discussion + Q&A
11:15 AM
CAR-T in MM
Krina Patel, MD, MSc (MD Anderson Cancer Center)
11:23 AM
CAR-T in NHL
Elise Chong, MD (University of Pennsylvania)
11:31 AM
Bispecifics in MM
Susan Bal, MD (University of Alabama at Birmingham)
11:39 AM
Bispecifics in NHL
Tycel Phillips, MD (City of Hope)
11:47 AM
Managing Acute Toxicities with Cellular and T-Cell Redirecting Therapies
11:55 AM
Panel Discussion + Q&A
12:15 AM
Remember the Future
Saad Usmani
1:55 PM
Utilizing Remote Consultation To Optomize Patient Care in The Community Setting
Jennifer Green, MD (Tennessee Oncology)
2:03 PM
Utilizing Frailty Indexes
Reena Jayani-Kosarzycki, MD, MSCI (Vanderbilt Health)
2:11 PM
Bringing Bispecifics to the Community
Tara Graff, DO, MS (Mission Cancer + Blood)
2:19 PM
Managing Long term toxicities with Cellular and T-Cell redirecting therapies
Adam Cohen, MD (University of Pennsylvania)
2:27 PM
Panel Discussion +Q&A
3:15 PM
MM
Ajay Nooka, MD, MPH (Emory Winship Cancer Institute)
3:23 PM
CLL
Deborah Stephens, DO (University of North Carolina School of Medicine)
3:31 PM
NHL
Ryan Jacobs, MD (Atrium Health Levine Cancer Institute)
3:39 PM
AML+MDS
Uma Borate, MBBS (The Ohio State University Comprehensive Cancer Center)
3:47 PM
MPNs +SM+CML
Kristen Pettit, MD (University of Michigan)
3:55 PM
Q&A
*Agenda is subject to change.
Experience Nashville, TN